SCHEMBL2324699

SCHEMBL2324699

CCC1(c2ccc(N(Cc3ccccc3)Cc3ccccc3)cc2)CCC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.51
TSHR P16473 2/20 0.49
CNR2 P34972 3/20 0.45
SLC6A3 Q01959 4/20 0.41
SLC6A4 P31645 4/20 0.41
SLC6A2 P23975 3/20 0.41
NR1H2 P55055 3/20 0.40
NR1H3 Q13133 3/20 0.40
LMNA P02545 3/20 0.39
OPRM1 P35372 2/20 0.39
KMT2A Q03164 2/20 0.39
CYP1A2 P05177 1/20 0.39
HTR1A P08908 1/20 0.39
ADRA2A P08913 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
CYP2D6 P10635 1/20 0.39
PDE6A P16499 1/20 0.39
ADRA2C P18825 1/20 0.39
MC4R P32245 1/20 0.39
ADRA1A P35348 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2327078 0.82 CYP2C19 (0.45) CYP2C19TSHRCNR2SLC6A3SLC6A4
SCHEMBL2327182 0.82 CYP2C19 (0.45) CYP2C19TSHRCNR2SLC6A3SLC6A4
SCHEMBL13364046 0.81 HSD11B1 (0.51) CYP2C19TSHRCNR2SLC6A3NR1H2
SCHEMBL2324374 0.80 CYP2C19 (0.43) CYP2C19TSHRCNR2SLC6A3SLC6A4
SCHEMBL13364192 0.80 GAA (0.48) CYP2C19TSHRCNR2SLC6A4LMNA
SCHEMBL10606137 0.78 DPP4 (0.57) SLC6A3SLC6A4SLC6A2LMNAOPRM1
SCHEMBL2323003 0.77 EPHX2 (0.44) CYP2C19TSHRCNR2SLC6A3NR1H2
SCHEMBL13364179 0.77 CYP2C19 (0.40) CYP2C19TSHRCNR2NR1H2NR1H3
SCHEMBL10776342 0.76 CYP2C19 (0.51) CYP2C19TSHRCNR2SLC6A3NR1H2
SCHEMBL3235304 0.74 CYP2C19 (0.53) CYP2C19TSHRCNR2SLC6A3NR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2356113-A1 HETEROCYCLICALLY SUBSTITUTED ARYL COMPOUNDS AS HIF INHIBITORS Bayer Schering Pharma Aktiengesellschaft (DE) 2011-08-17 EP disclosed
WO-2010054763-A1 HETEROCYCLICALLY SUBSTITUTED ARYL COMPOUNDS AS HIF INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-05-20 WO disclosed